Initial studies indicate that targeting peroxisomes could mitigate cognitive impairment and neurodegeneration in AD models, highlighting the potential of ACBD5 as a therapeutic target for Alzheimer’s disease. The gene discussed is ACBD5; the disease is Cognitive impairment.